Harvard researchers have developed FaceAge, an AI tool that estimates biological age through facial analysis. The model, trained on nearly 59,000 healthy faces, shows potential in predicting cancer survival outcomes based on appearance.
- FaceAge AI correlates older facial appearance with poorer cancer survival outcomes.
- Trained on 58,851 healthy faces and tested on cancer patients for prognostic accuracy.
- Part of Harvard's broader AI-driven research into aging and cancer diagnostics.
📎 Related coverage from: decrypt.co
